The estimated Net Worth of Joseph A. De John is at least $58.7 Tausend dollars as of 1 June 2016. Joseph John owns over 957 units of Endologix stock worth over $34,726 and over the last 16 years Joseph sold ELGX stock worth over $24,021.
Joseph has made over 2 trades of the Endologix stock since 2016, according to the Form 4 filled with the SEC. Most recently Joseph sold 957 units of ELGX stock worth $12,010 on 1 June 2016.
The largest trade Joseph's ever made was selling 957 units of Endologix stock on 1 June 2016 worth over $12,010. On average, Joseph trades about 120 units every 0 days since 2008. As of 1 June 2016 Joseph still owns at least 157,847 units of Endologix stock.
You can see the complete history of Joseph John stock trades at the bottom of the page.
Joseph's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott und Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: